top of page
Varolis
image.png
Vision

By combining apidology research and professional bee keeping practice, VAROLIS will
become the global provider for a more effective, better tolerated and safer medicine for honey
bees.

image.png
Mission

Saving honey bees to safeguard pollination, global food supply and a healthy
environment

image.png
History

Varolis was founded to bundle IP, knowledge, research data and expertise into one company with
the aim to develop Lithium as veterinary drug under the trade name LIMITEX a novel,
effective and easy to apply agent to control the parasitic Varroa mites (Varroa destructor).

About Varolis

Varolis

Our Honeybee

TST_8395.jpg

About Limitex

uptime_8629491.png
Efficent

Compared to all other treatment option our systemic Lithium treatment has by far the highestefficacy under field conditions. In experiments carried out at the Apicultural State Institute inHohenheim efficacies significantly exceeding 95% were obtained reproducibly over several years oftesting and 97,5% using Lithium Citrate in a study carried out in 2023.

padlock_11919157.png
Save

Lithium is well tolerated by adult bees.  Throughout the shortperiod of treatment time Lithium at the indicated concentration has no impact on bee health. Asingle treatment instead of multiple interventions is also beneficial for colony condition.

No residues in bee products. Similarly, only 25 days post treatment Lithium concentrations werenot found to be elevated in honey compared to control. Other than synthetic compounds Lithium will not induce resistanceformation and lose efficacy over time.

easy_5278675.png
Easy to use

​​The systemic mode of action allows to feed the anti-Varroamite drug rather the vaporize or spray ortrickle. A single treatment is sufficient to remove mites efficiently and lowers the work load of beekeepers. The treatment coincides with the annual feeding with sucrose syrup and therefore does notimply additional work.

Elimte
Varolis

Varroa

bee-85576_1280.jpg

Team

The Team of Varolis combines know how and experiences in the fields of Apidology and Apiculture, Biology, Biochemistry, Drug Discovery and -development, Regulatory Affairs, Investor Relations, Finance, Business Development as well as Intellectual Property Rights,

image.png

Dr. Stefan Hannus

Founder / CEO

image.png

Prof. Dr. Uwe Jacob

Founder / CDO

image.png

Dr. Dirk Bühler

Founder / Patent Lawyer

image.png

Dr. Frank Becker

Founder / CFO

For Investors

Why you should invest in Varolis
global-market_12166627.png
Global market

Global market volume of 2 billion euros. An serviceable market of approx. 500 million euros

business-cycle_12771878.png
Fast ROI

The break-even point is expected to be reached in 2029/30. With a market share of approx. 3% and an estimated turnover of 10-15 million euros

saving-hands-with-a-bee.png
Save the bees

With Limitex, it is possible to revolutionize the market for varroa treatment and eliminate the greatest threat to the honey bee, thus making a significant contribution to saving the bee

Supportiv association
bottom of page